Delivery Order SPE2DB25D3020-SPE2DB25FWJPZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Nucynta ER 50 mg tablets (60-count), with a contract ceiling value of $1,398.37. This is a firm fixed-price delivery order with no set-aside designation, demonstrating competitive award to the contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $10,441.56 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- The Defense Logistics Agency awarded a $1,837.60 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Nucynta 50 mg tablets (100-count packages). This firm fixed-price contract, which is not set-aside and competitively awarded, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order valued at $1,592.44 to AmerisourceBergen Drug Corp for Nucynta ER 50 mg tablets (60-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Nucynta ER 200 mg tablets (60-count units) at a ceiling value of $3,670.09. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitive award. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,347.68 for 100 tablets of Nucynta 50 mg on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. Nucynta is a pain management pharmaceutical used across military and federal healthcare systems. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,944.08 under a firm fixed-price contract. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. The award was competitively...
- This delivery order, awarded on July 23, 2025, by the Defense Logistics Agency's Medical Supply Chain division, provides for the supply of Nucynta Tabs 50mg, a prescription pain management medication, to support federal medical procurement needs. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on a firm fixed-price basis with a ceiling value of $4,442.48 and an ultimate completion date of July 24, 2025. This...
- This is a firm fixed-price delivery order for $1,351.56 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,566,050,409 units of the pharmaceutical product NUCYNTA 75 MG TABLET 100S. The ultimate completion date for the order is October 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Nucynta ER 50 mg tablets in quantities of 60 units. The contract carries a ceiling value of $1,414.00 and features firm fixed pricing with an ultimate completion date of July 25, 2025. This is a non-set-aside award issued competitively and represents a child contract under AmerisourceBergen's existing...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWJPZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Nucynta 50 mg tablets (100 count) with a ceiling value of $1,225.04. This firm fixed-price delivery order, with an ultimate completion date of July 23, 2025, represents a direct fulfillment of pharmaceutical needs through the federal medical supply chain. The contract is not set-aside and was competitively awarded, reflecting AmerisourceBergen's established capability as a critical vendor for federal healthcare procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a child contract under this prime indefinite delivery vehicle, this order exemplifies the company's comprehensive role in providing pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal portfolio demonstrates consistent competitively awarded contracts for diverse therapeutic domains, positioning the company as a primary pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/22/25 |